MX9102684A - Metodo para construir secuencias de peptido lider, sinteticas. - Google Patents

Metodo para construir secuencias de peptido lider, sinteticas.

Info

Publication number
MX9102684A
MX9102684A MX9102684A MX9102684A MX9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A MX 9102684 A MX9102684 A MX 9102684A
Authority
MX
Mexico
Prior art keywords
lider
peptido
synthetics
build sequences
build
Prior art date
Application number
MX9102684A
Other languages
English (en)
Inventor
Lars Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9102684A publication Critical patent/MX9102684A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Consolidation Of Soil By Introduction Of Solidifying Substances Into Soil (AREA)
MX9102684A 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas. MX9102684A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Publications (1)

Publication Number Publication Date
MX9102684A true MX9102684A (es) 1992-06-01

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102684A MX9102684A (es) 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas.

Country Status (17)

Country Link
EP (1) EP0563175A1 (es)
JP (1) JPH06503957A (es)
KR (1) KR930703450A (es)
AU (1) AU660161B2 (es)
CA (1) CA2098731A1 (es)
CZ (1) CZ119293A3 (es)
DK (1) DK300090D0 (es)
FI (1) FI932831A0 (es)
HU (1) HUT68751A (es)
IE (1) IE914433A1 (es)
IL (1) IL100408A0 (es)
MX (1) MX9102684A (es)
NZ (1) NZ241011A (es)
PT (1) PT99848A (es)
SK (1) SK62593A3 (es)
WO (1) WO1992011378A1 (es)
ZA (1) ZA919932B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
ZA954983B (en) * 1994-06-17 1996-02-14 Novo Nordisk As N-terminally extended proteins expressed in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
CN1182451A (zh) 1995-03-17 1998-05-20 诺沃挪第克公司 新的内切葡聚糖酶
DK1975177T3 (da) 1996-03-01 2011-07-25 Novo Nordisk As Appetitundertrykkende peptid, formuleringer dermed og anvendelse deraf
ES2306462T3 (es) * 1996-12-13 2008-11-01 Novartis Vaccines And Diagnostics, Inc. Analisis y separacion de proteinas del factor de crecimiento derivadas de plaquetas.
KR20010034305A (ko) 1998-01-23 2001-04-25 한센 핀 베네드 효모에서 원하는 폴리펩티드를 만드는 방법
CN1415019A (zh) 1999-12-29 2003-04-30 诺沃挪第克公司 用于生产在酵母中具有改进发酵产量的胰岛素前体和胰岛素前体类似物的方法
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
PL371800A1 (en) 2001-03-22 2005-06-27 Novo Nordisk Health Care Ag Coagulation factor vii derivatives
ES2376694T3 (es) 2001-09-27 2012-03-16 Novo Nordisk Health Care Ag Polipã‰ptidos del factor vii de coagulaciã“n humano.
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
JP2007532096A (ja) 2003-11-14 2007-11-15 ノボ ノルディスク アクティーゼルスカブ アシル化されたインスリンの製造方法
ATE517119T1 (de) 2003-12-03 2011-08-15 Novo Nordisk As Einzelketteninsulin
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
US8034326B2 (en) 2005-04-18 2011-10-11 Novo Nordisk A/S IL-21 variants
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
US20090055942A1 (en) 2005-09-14 2009-02-26 Novo Nordisk Healthcare A/G Human Coagulation Factor VII Polypeptides
DE602007009496D1 (de) 2006-02-27 2010-11-11 Novo Nordisk As Insulinderivate
WO2008037735A1 (en) 2006-09-27 2008-04-03 Novo Nordisk A/S Method for making maturated insulin polypeptides
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
KR20100053561A (ko) 2007-08-15 2010-05-20 노보 노르디스크 에이/에스 아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
JP5721432B2 (ja) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー/エス アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
US20120107267A1 (en) 2009-03-11 2012-05-03 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
EP3395828A1 (en) 2009-07-17 2018-10-31 Rigshospitalet Inhibitors of complement activation
US8815541B2 (en) 2009-11-25 2014-08-26 Novo Nordisk A/S Method for making polypeptides
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
EP2526117B1 (en) 2010-01-22 2015-05-06 Novo Nordisk A/S Process for preparing fgf-21 with low degree of o-glycosylation
WO2011107591A1 (en) 2010-03-05 2011-09-09 Rigshospitalet Chimeric inhibitor molecules of complement activation
CA2806399A1 (en) * 2010-07-28 2012-02-02 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
JP6517018B2 (ja) 2012-02-09 2019-05-22 ヴァー2・ファーマシューティカルズ・アンパルトセルスカブVAR2 Pharmaceuticals ApS コンドロイチン硫酸グリカンのターゲティング
CN104704118A (zh) 2012-10-15 2015-06-10 诺和诺德保健Ag(股份有限公司) 凝血因子vii多肽
WO2014195452A1 (en) 2013-06-07 2014-12-11 Novo Nordisk A/S Method for making mature insulin polypeptides
CN106029688A (zh) * 2014-02-28 2016-10-12 诺和诺德股份有限公司 交配因子α原肽变体
EP3821244A1 (en) 2018-07-13 2021-05-19 Varct Diagnostics ApS Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
JP3092811B2 (ja) * 1988-07-23 2000-09-25 デルタ バイオテクノロジー リミテッド ペプチドおよびdna配列
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
JPH06503957A (ja) 1994-05-12
CA2098731A1 (en) 1992-06-19
CZ119293A3 (en) 1994-02-16
PT99848A (pt) 1993-06-30
ZA919932B (en) 1992-08-26
DK300090D0 (da) 1990-12-19
AU9134891A (en) 1992-07-22
HUT68751A (en) 1995-07-28
NZ241011A (en) 1993-04-28
AU660161B2 (en) 1995-06-15
KR930703450A (ko) 1993-11-30
WO1992011378A1 (en) 1992-07-09
EP0563175A1 (en) 1993-10-06
HU9301801D0 (en) 1993-10-28
IL100408A0 (en) 1992-09-06
SK62593A3 (en) 1993-10-06
FI932831A (fi) 1993-06-18
IE914433A1 (en) 1992-07-01
FI932831A0 (fi) 1993-06-18

Similar Documents

Publication Publication Date Title
MX9102684A (es) Metodo para construir secuencias de peptido lider, sinteticas.
ES516294A0 (es) Un metodo para la preparacion de un peptido inhibidor de la renina.
ES548388A0 (es) Un procedimiento para la preparacion de un peptido.
DE69530681D1 (de) (4,4-difluorbut-3-enylthio)-substituierte heterocyckische oder carbocyclische ring-verbindungen mit pesticider wirkung
BR9106139A (pt) Solucao catalisadora de paladio aquosa,processo wacker para fabricacao de acetaldeido,processo para oxidacao de olefina,e processo para oxidacao de vanadio (iv)
MX9206450A (es) Proceso para la produccion de isoleucina-l.
MX9203870A (es) Metodo para la produccion de granulos.
ES556363A0 (es) Procedimiento para la produccion de tiazoles.,
AR017053A1 (es) Un proceso mejorado de recuperacinn de compuestos aromrticos
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
MX9102598A (es) Metodo para fabricar l-lisina granulada.
ES557639A0 (es) Procedimiento para la obtencion de 2,2-difluoro-4-amino-1,3-benzodioxol
BR9714066B1 (pt) processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço.
DE69431992D1 (de) Verbessertes, telomerisiertes ölprodukt
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
ID19571A (id) Proses pemurnian 1,4-butanadiol mentah
MX9200841A (es) Proceso mejorado para la preparacion de dinitrotolueno.
ES522559A0 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
ITTO930806A0 (it) Purificazione dell' 1,1-dicloro-1-fluoroetano.
ES2021048B3 (es) Un metodo para la preparacion de un derivado de 2,4-diamino-3oxi-pirimidina.
KR900700426A (ko) 지방족 1,2-디올의 탈수소화 방법
IT1226098B (it) Nuovi composti fluorurati e processo per la loro preparazione.
BR9305542A (pt) Processo para a preparação de 5-alcóxi-2,4-dinitro-alquilbenzenos
NO891320D0 (no) Selektiv foroekning av maalpolynuklotidsekvenser.
NO932070D0 (no) Vandig, polymert viskositetsoekende preparat